{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:31:46Z","timestamp":1789507906426,"version":"build-2803163510"},"reference-count":77,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01512","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T08:22:39Z","timestamp":1562314959000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Concurrent Exposure of Neutralizing and Non-neutralizing Epitopes on a Single HIV-1 Envelope Structure"],"prefix":"10.3389","volume":"10","author":[{"given":"Krishanu","family":"Ray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meron","family":"Mengistu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzena","family":"Pazgier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George K.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony L.","family":"DeVico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,7,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/31405","article-title":"Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody","volume":"393","author":"Kwong","year":"1998","journal-title":"Nature."},{"key":"B2","doi-asserted-by":"crossref","first-page":"10373","DOI":"10.1016\/S0021-9258(18)86956-3","article-title":"Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells","volume":"265","author":"Leonard","year":"1990","journal-title":"J Biol Chem."},{"key":"B3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody neutralization and escape by HIV-1","volume":"422","author":"Wei","year":"2003","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.1073\/pnas.82.14.4813","article-title":"Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes","volume":"82","author":"Hahn","year":"1985","journal-title":"Proc Natl Acad Sci USA."},{"key":"B5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1089\/aid.2005.21.171","article-title":"V3: HIV's switch-hitter","volume":"21","author":"Hartley","year":"2005","journal-title":"AIDS Res Hum Retroviruses."},{"key":"B6","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/334440a0","article-title":"Extensive variation of human immunodeficiency virus type-1 in vivo","volume":"334","author":"Saag","year":"1988","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/31514","article-title":"The antigenic structure of the HIV gp120 envelope glycoprotein","volume":"393","author":"Wyatt","year":"1998","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"14943","DOI":"10.1073\/pnas.0505126102","article-title":"Antibody vs. HIV in a clash of evolutionary titans","volume":"102","author":"Burton","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"B9","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/s41598-017-00935-w","article-title":"Flow virometry analysis of envelope glycoprotein conformations on individual HIV virions","volume":"7","author":"Arakelyan","year":"2017","journal-title":"Sci Rep"},{"key":"B10","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1128\/JVI.66.2.848-856.1992","article-title":"Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120","volume":"66","author":"Fung","year":"1992","journal-title":"J Virol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1126\/science.2431482","article-title":"HTLV-III\/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope","volume":"234","author":"Putney","year":"1986","journal-title":"Science"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1073\/pnas.85.9.3198","article-title":"Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120","volume":"85","author":"Rusche","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"B13","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/S0952-7915(96)80044-6","article-title":"Neutralization of HIV-1 by antibody","volume":"8","author":"Sattentau","year":"1996","journal-title":"Curr Opin Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.cell.2018.03.061","article-title":"Identification of near-pan-neutralizing antibodies against HIV-1 by deconvolution of plasma humoral responses","volume":"173","author":"Sajadi","year":"2018","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1126\/science.1192819","article-title":"Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01","volume":"329","author":"Zhou","year":"2010","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/s41590-018-0235-7","article-title":"Recent progress in broadly neutralizing antibodies to HIV","volume":"19","author":"Sok","year":"2018","journal-title":"Nat Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"18921","DOI":"10.1073\/pnas.1214785109","article-title":"Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo","volume":"109","author":"Moldt","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.immuni.2018.11.011","article-title":"Vaccine-induced protection from homologous tier 2 SHIV challenge in nonhuman primates depends on serum-neutralizing antibody titers","volume":"50","author":"Pauthner","year":"2019","journal-title":"Immunity"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e1000433","DOI":"10.1371\/journal.ppat.1000433","article-title":"Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers","volume":"5","author":"Hessell","year":"2009","journal-title":"PLoS Pathog"},{"key":"B20","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2174\/157016207782418560","article-title":"CD4-induced epitopes in the HIV envelope glycoprotein, gp120","volume":"5","author":"DeVico","year":"2007","journal-title":"Curr HIV Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e1004772","DOI":"10.1371\/journal.ppat.1004772","article-title":"Antigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cells","volume":"11","author":"Mengistu","year":"2015","journal-title":"PLoS Pathog"},{"key":"B22","doi-asserted-by":"publisher","first-page":"E69","DOI":"10.1073\/pnas.1217609110","article-title":"Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding","volume":"110","author":"Guan","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B23","doi-asserted-by":"publisher","first-page":"E9893","DOI":"10.1073\/pnas.1705074114","article-title":"Patterns of conserved gp120 epitope presentation on attached HIV-1 virions","volume":"114","author":"Mengistu","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1128\/JVI.77.2.1084-1091.2003","article-title":"Nonneutralizing antibodies to the CD4-binding site on the gp120 subunit of human immunodeficiency virus type 1 do not interfere with the activity of a neutralizing antibody against the same site","volume":"77","author":"Herrera","year":"2003","journal-title":"J Virol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1128\/JVI.77.1.353-365.2003","article-title":"Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies","volume":"77","author":"Poignard","year":"2003","journal-title":"J Virol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1128\/JVI.80.5.2515-2528.2006","article-title":"Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1","volume":"80","author":"Moore","year":"2006","journal-title":"J Virol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/0140-6736(90)93310-L","article-title":"Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by fixed infected-cell vaccine","volume":"336","author":"Stott","year":"1990","journal-title":"Lancet"},{"key":"B28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-0684.1992.tb00567.x","article-title":"Protection against SIV infection in macaques by immunization with inactivated virus from the BK28 molecular clone, but not with BK28-derived recombinant env and gag proteins","volume":"21","author":"Mills","year":"1992","journal-title":"J Med Primatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/353393a0","article-title":"Anti-cell antibody in macaques","volume":"353","author":"Stott","year":"1991","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e88735","DOI":"10.1371\/journal.pone.0088735","article-title":"Complement-mediated virus infectivity neutralisation by HLA antibodies is associated with sterilising immunity to SIV challenge in the macaque model for HIV\/AIDS","volume":"9","author":"Page","year":"2014","journal-title":"PLoS ONE"},{"key":"B31","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.cell.2017.06.048","article-title":"Non-neutralizing antibodies alter the course of HIV-1 infection in vivo","volume":"170","author":"Horwitz","year":"2017","journal-title":"Cell"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1128\/JVI.02363-09","article-title":"In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1","volume":"84","author":"Leaman","year":"2010","journal-title":"J Virol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1128\/JVI.03765-13","article-title":"Capacity for infectious HIV-1 virion capture differs by envelope antibody specificity","volume":"88","author":"Liu","year":"2014","journal-title":"J Virol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12977-015-0207-z","article-title":"Discrete partitioning of HIV-1 Env forms revealed by viral capture","volume":"12","author":"Stieh","year":"2015","journal-title":"Retrovirology."},{"key":"B35","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.virol.2005.05.002","article-title":"The impact of envelope glycoprotein cleavage on the antigenicity, infectivity, and neutralization sensitivity of Env-pseudotyped human immunodeficiency virus type 1 particles","volume":"338","author":"Herrera","year":"2005","journal-title":"Virology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1128\/JVI.03048-13","article-title":"Antigenic properties of the HIV envelope on virions in solution","volume":"88","author":"Ray","year":"2014","journal-title":"J Virol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1089\/aid.1998.14.1271","article-title":"Functional and molecular characterization of human monoclonal antibody reactive with the immunodominant region of HIV type 1 glycoprotein 41","volume":"14","author":"Cavacini","year":"1998","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B38","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1128\/JVI.65.9.4832-4838.1991","article-title":"Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies","volume":"65","author":"Xu","year":"1991","journal-title":"J Virol"},{"key":"B39","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.4049\/jimmunol.145.10.3276","article-title":"Identification of sites within gp41 that serve as targets for antibody-dependent cellular cytotoxicity by using human monoclonal antibodies","volume":"145","author":"Tyler","year":"1990","journal-title":"J Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1097\/00002030-200212060-00005","article-title":"Interactions of human antibodies, epitope exposure, antibody binding and neutralization of primary isolate HIV-1 virions","volume":"16","author":"Cavacini","year":"2002","journal-title":"AIDS"},{"key":"B41","doi-asserted-by":"publisher","first-page":"36685","DOI":"10.1038\/srep36685","article-title":"Molecular basis for epitope recognition by non-neutralizing anti-gp41 antibody F240","volume":"6","author":"Gohain","year":"2016","journal-title":"Sci Rep"},{"key":"B42","doi-asserted-by":"publisher","first-page":"11181","DOI":"10.1073\/pnas.1103012108","article-title":"Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody","volume":"108","author":"Burton","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e1005042","DOI":"10.1371\/journal.ppat.1005042","article-title":"Human non-neutralizing HIV-1 envelope monoclonal antibodies limit the number of founder viruses during SHIV mucosal infection in rhesus macaques","volume":"11","author":"Santra","year":"2015","journal-title":"PLoS Pathog"},{"key":"B44","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.1128\/JVI.77.10.5678-5684.2003","article-title":"Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions","volume":"77","author":"Binley","year":"2003","journal-title":"J Virol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1128\/JVI.80.3.1414-1426.2006","article-title":"Characterization of antibody responses elicited by human immunodeficiency virus type 1 primary isolate trimeric and monomeric envelope glycoproteins in selected adjuvants","volume":"80","author":"Li","year":"2006","journal-title":"J Virol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e1000890","DOI":"10.1371\/journal.ppat.1000890","article-title":"High multiplicity infection by HIV-1 in men who have sex with men","volume":"6","author":"Li","year":"2010","journal-title":"PLoS Pathog"},{"key":"B47","doi-asserted-by":"publisher","first-page":"11776","DOI":"10.1128\/JVI.01730-06","article-title":"Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa","volume":"80","author":"Li","year":"2006","journal-title":"J Virol"},{"key":"B48","doi-asserted-by":"crossref","first-page":"7992","DOI":"10.1128\/JVI.72.10.7992-8001.1998","article-title":"Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins","volume":"72","author":"Rossio","year":"1998","journal-title":"J Virol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.vaccine.2014.10.054","article-title":"Autologous aldrithiol-2-inactivated HIV-1 combined with polyinosinic-polycytidylic acid-poly-L-lysine carboxymethylcellulose as a vaccine platform for therapeutic dendritic cell immunotherapy","volume":"33","author":"Miller","year":"2015","journal-title":"Vaccine."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1128\/JVI.75.6.2993-3000.2001","article-title":"Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions","volume":"75","author":"Schaeffer","year":"2001","journal-title":"J Virol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1021\/bi0118512","article-title":"Biological and chemical applications of fluorescence correlation spectroscopy: a review","volume":"41","author":"Hess","year":"2002","journal-title":"Biochemistry"},{"key":"B52","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nmeth822","article-title":"Fluorescence cross-correlation spectroscopy in living cells","volume":"3","author":"Bacia","year":"2006","journal-title":"Nat Methods"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/S0006-3495(97)78833-7","article-title":"Dual-color fluorescence cross-correlation spectroscopy for multicomponent diffusional analysis in solution","volume":"72","author":"Schwille","year":"1997","journal-title":"Biophys J"},{"key":"B54","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/pro.5560010502","article-title":"Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution-state structure of the nucleocapsid protein from HIV-1","volume":"1","author":"Summers","year":"1992","journal-title":"Protein Sci"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1128\/CVI.00066-10","article-title":"Characterization of immune responses to capsid protein p24 of human immunodeficiency virus type 1 and implications for detection","volume":"17","author":"Tang","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nature01060","article-title":"Probing the free-energy surface for protein folding with single-molecule fluorescence spectroscopy","volume":"419","author":"Schuler","year":"2002","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.virol.2009.11.047","article-title":"DNA crunching by a viral packaging motor: compression of a procapsid-portal stalled Y-DNA substrate","volume":"398","author":"Ray","year":"2010","journal-title":"Virology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"18878","DOI":"10.1074\/jbc.M111.222828","article-title":"Dynamics of the T4 bacteriophage DNA packasome motor: endonuclease VII resolvase release of arrested Y-DNA substrates","volume":"286","author":"Dixit","year":"2011","journal-title":"J Biol Chem"},{"key":"B59","doi-asserted-by":"publisher","first-page":"20419","DOI":"10.1073\/pnas.1214318109","article-title":"Compression of the DNA substrate by a viral packaging motor is supported by removal of intercalating dye during translocation","volume":"109","author":"Dixit","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"key":"B60","doi-asserted-by":"publisher","first-page":"8840","DOI":"10.1128\/JVI.01232-15","article-title":"Cocrystal structures of antibody N60-i3 and antibody JR4 in complex with gp120 define more cluster A epitopes involved in effective antibody-dependent effector function against HIV-1","volume":"89","author":"Gohain","year":"2015","journal-title":"J Virol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature07159","article-title":"Molecular architecture of native HIV-1 gp120 trimers","volume":"455","author":"Liu","year":"2008","journal-title":"Nature."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1126\/science.1083182","article-title":"Antibody domain exchange is an immunological solution to carbohydrate cluster recognition","volume":"300","author":"Calarese","year":"2003","journal-title":"Science"},{"key":"B63","doi-asserted-by":"publisher","first-page":"13372","DOI":"10.1073\/pnas.0505763102","article-title":"Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12","volume":"102","author":"Calarese","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1126\/science.7973652","article-title":"Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody","volume":"266","author":"Burton","year":"1994","journal-title":"Science"},{"key":"B65","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1128\/JVI.72.6.4694-4703.1998","article-title":"CD4-Induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization","volume":"72","author":"Sullivan","year":"1998","journal-title":"J Virol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1096\/fj.05-5509rev","article-title":"Computational prediction of the cross-reactive neutralizing epitope corresponding to the [corrected] monclonal [corrected] antibody b12 specific for HIV-1 gp120","volume":"20","author":"Bublil","year":"2006","journal-title":"Faseb J"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1126\/science.aad2450","article-title":"Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer","volume":"351","author":"Lee","year":"2016","journal-title":"Science"},{"key":"B68","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1126\/science.1178746","article-title":"Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target","volume":"326","author":"Walker","year":"2009","journal-title":"Science"},{"key":"B69","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/nature10696","article-title":"Structure of HIV-1 gp120 V1\/V2 domain with broadly neutralizing antibody PG9","volume":"480","author":"McLellan","year":"2011","journal-title":"Nature"},{"key":"B70","doi-asserted-by":"publisher","first-page":"27389","DOI":"10.7554\/eLife.27389","article-title":"Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies","volume":"6","author":"Wang","year":"2017","journal-title":"Elife"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e01696","DOI":"10.1128\/JVI.01696-18","article-title":"Broadly cross-reactive, non-neutralizing antibodies against the influenza B virus hemagglutinin demonstrate effector function dependent protection against lethal viral challenge in mice","volume":"93","author":"Arunkumar","year":"2019","journal-title":"J Virol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.cell.2018.07.033","article-title":"Systematic analysis of monoclonal antibodies against ebola virus GP defines features that contribute to protection","volume":"174","author":"Saphire","year":"2018","journal-title":"Cell"},{"key":"B73","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.chom.2018.07.009","article-title":"A role for Fc function in therapeutic monoclonal antibody-mediated protection against ebola virus","volume":"24","author":"Gunn","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/s41590-018-0233-9","article-title":"Antibody-mediated protection against Ebola virus","volume":"19","author":"Saphire","year":"2018","journal-title":"Nat Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"30036","DOI":"10.3390\/vaccines6030036","article-title":"The role of Fc gamma receptors in broad protection against influenza viruses","volume":"6","author":"Thulin","year":"2018","journal-title":"Vaccines"},{"key":"B76","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.4049\/jimmunol.1400822","article-title":"Live simian immunodeficiency virus vaccine correlate of protection: immune complex-inhibitory Fc receptor interactions that reduce target cell availability","volume":"193","author":"Smith","year":"2014","journal-title":"J Immunol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.4049\/jimmunol.1400820","article-title":"Live simian immunodeficiency virus vaccine correlate of protection: local antibody production and concentration on the path of virus entry","volume":"193","author":"Li","year":"2014","journal-title":"J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01512\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T00:27:02Z","timestamp":1694996822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01512\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,5]]},"references-count":77,"alternative-id":["10.3389\/fimmu.2019.01512"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01512","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,5]]},"article-number":"1512"}}